首页 | 本学科首页   官方微博 | 高级检索  
     


Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: Data from the Israeli ICD Registry
Affiliation:2. Rambam Medical Center, Haifa, Israel;3. Department of Cardiology, Tel Hashomer Medical Center, Tel Aviv, Israel;4. Naharia Medical Center, Naharia, Israel;5. Department of Cardiology, Wolfson Medical Center, Holon, Israel;11. Arrhythmia Therapy Center, Heart Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel;12. Department of Cardiology, Ha׳Emek Medical Center, Afula, Israel;2. The Section of Cardiac Electrophysiology, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;2. Division of Cardiology, Department of Medical Sciences, San Giovanni Battista Hospital, University of Turin, Turin, Italy;2. Department of Cardiology, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Denmark;3. Division of Cardiovascular Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan;2. IDIBAPS (Institut d’Investigació Agustí Pi i Sunyer), Barcelona, Spain;3. Arrhythmia Unit, Cardiology Department, Hospital Universitario Virgen del Rocío, Seville, Spain;2. Department of Medicine, University of California, San Francisco, San Francisco, California;3. Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California
Abstract:
Keywords:Defibrillation threshold  Defibrillation threshold testing  Implantable cardioverter-defibrillator  Mortality  Complications  Outcomes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号